Late stage adjuvant mimics based on TLR4 agonists
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93022C00004
- Awardee
-
PAI Life Sciences Inc. UEI MSMLUCM9DRT6
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $597,953
Award facts
- Opportunity
-
- PHS202101 Solicitation number
- Contract value 100% obligated
- $597,953.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Seattle, WA 98102, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $597,953 |
About this award
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded PAI Life Sciences Inc. a $597,953 definitive contract to develop late stage adjuvant mimics based on toll-like receptor 4 agonists. As a self-certified small disadvantaged business, this contract was designated as a total small business set aside. PAI Life Sciences will provide products and services to the National Institute of Allergy and Infectious Diseases in support of their program for late stage adjuvant development using toll-like receptor 4 agonists. Work will be conducted in Seattle, Washington and is expected to be completed by January 2024. No subcontractors were identified.
Quick answers
Who was awarded contract 75N93022C00004?
75N93022C00004 was awarded to PAI Life Sciences Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 10, 2022.
How much is contract 75N93022C00004 worth?
The government has obligated $597,953 on 75N93022C00004.
Was contract 75N93022C00004 competed?
The extent of competition for 75N93022C00004 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award